With facilities in the US. the UK and in India, Pharmazz, Inc. is a clinical stage pharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target products for the diagnosis and treatment of clinical conditions that require critical care and hospital settings. Pharmazz is working on several technologies for the treatment of Hypovolemic shock, Cardiac arrest, Post-operative pain, Ischemic stroke, Alzheimer disease, Diabetic ketoacidosis and is also developing product for tumor diagnosis. Patents for these technologies have been granted in the USA, Europe, China, Canada, Australia, India and other countries. In addition, there are pending patents and additional patent applications are constantly being filed. for use in critical care and hospital settings . The company is developing several clinical-stage product candidates, PMZ-2010, PMZ-1620 and PMZ-2123 for which it holds global marketing rights. Pharmazz personnel are working on several technologies for the treatment of Hypovolemic shock, Cardiac arrest, Post-operative pain, Ischemic stroke, Alzheimer disease, Diabetic ketoacidosis and is also developing product for tumor diagnosis. Patents for these technologies have been granted in the USA, Europe, China, Canada, Australia, India and other countries. In addition, there are pending patents and additional patent applications are constantly being filed.
